You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Trutek Corp. v. BlueWillow Biologics, Inc. (E.D. Mich. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Trutek Corp. v. BlueWillow Biologics, Inc.
The small molecule drug covered by the patents cited in this case is ⤷  Sign Up .
Biologic Drugs cited in Trutek Corp. v. BlueWillow Biologics, Inc.
The biologic drugs covered by the patents cited in this case are ⤷  Sign Up and ⤷  Sign Up .

Details for Trutek Corp. v. BlueWillow Biologics, Inc. (E.D. Mich. 2021)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2021-06-25 12 Response to Motion 6,559,189; U.S. Patent No. 6,506,803; U.S. Patent No. 10,138,279; U.S. Published… 6,506,803; U.S. Patent No. 10,138,279; U.S. Published Application No. 2006/0163149; U.S. Published …one count of patent infringement of United States Patent No. 8,163,802 (“the ’802 Patent”) against BlueWillow…’802 Patent invalid under 35 U.S.C. § 102 and/or § 103: U.S. Patent No. 6,559,189; U.S. Patent No. 6,506,803…BlueWillow did not infringe Trutek’s patent; and (ii) Trutek’s patent is invalid. Trutek External link to document
2021-10-20 16 Answer to Counterclaim 6,559,189; U.S. Patent No. 6,506,803; U.S. Patent No. 10,138,279; U.S. 19 Published Application…infringement of 11 U.S. Patent No. 8,163,802 ("the '802 Patent") by BlueWillow, but …suit alleging one count of patent infringement 15 of the '802 Patent against BlueWillow. 16 … '802 Patent invalid under 35 U.S.C. § 102 and/or § 103; U.S. Patent No. 18 …Further, while Defendant cited four patents and 23 two patent application publications to support External link to document
2022-05-11 28 Exhibit Proposed Amended Complaint the Same." c. U.S. Patent No. 10,138,279 issued on November 27, 2018 to James R. …proper under the Patent Venue Statute, 28 U.S.C. § 1400(b) since the tort of patent infringement occurred…1995, United States Patent No. 5,468,488 (hereinafter the '488 Patent) was issued to WAHI …x27;488 Patent was assigned to TRUTEK. 8. On October 7, 1997, United States Patent No. 5,674,481…2005, United States Patent No. 6,844,005 (hereinafter the '005 Patent) was issued to WAHI External link to document
2022-05-25 30 Exhibit E - October 25, 2021 Email from S. Kremen to L. Peterson and Attached Oc 206,996; and 10,525,121, all assigned to Nanobio. Further, I reviewed United States PatentNumbers 7,314,624… associated with the Nanobio patents. It is my belief that these patents as well as other publications…claims 1 and 2 of the.'802 Patent (owned by Tfutek) wifh the patents apd other publications describins…researched the patents'claims of both Trutek and Blue Willow and noting the patents and public armouncements…14312. At your request, I reviewed United States Patent No. 8,163,802 (hereinafter the '802 PatenJ External link to document
2022-09-26 39 Exhibit 1 - Trutek's Interrogatory Answers No. 6,506,803; U.S. Patent No. 10,138,279; U.S. Published Application No. 2006/0163149; U.S. Published…The term "Asserted Patent" or “Patent-in-Suit” shall mean U.S. Patent No. 8,163,802 (…802 Patent invalid under 35 U.S.C. § 102 and/or § 103: U.S. Patent No. 6,559,189; U.S. Patent …identifying each patent claim that You contend has been infringed by the asserted patent or will be … of the '802 Patent invalid. According to the law, the '802 Patent is presumed valid External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.